세계의 유방 생검 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for breast biopsy devices. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Breast Biopsy Market Size (2025E): USD 2,465.9 Million
• Projected Market Value (2032F): USD 3,587.1 Million
• Global Market Growth Rate (CAGR 2025 to 2032): 5.5%

Breast Biopsy Market - Report Scope:

Breast biopsy is a critical diagnostic procedure employed to evaluate suspicious breast abnormalities and confirm or rule out the presence of breast cancer. Techniques include core needle biopsy, vacuum-assisted biopsy, and fine needle aspiration, guided by imaging modalities such as ultrasound, stereotactic systems, and MRI. The market serves hospitals, diagnostic centers, and ambulatory surgical centers with devices ranging from needle-based biopsy instruments to advanced imaging-guided systems. Market growth is driven by the rising global incidence of breast cancer, increased awareness about early cancer detection, and the adoption of minimally invasive procedures that reduce patient discomfort and recovery time.

Market Growth Drivers:

The global breast biopsy market is propelled by the rising prevalence of breast cancer, one of the leading causes of cancer-related deaths among women globally. Increased emphasis on routine screening and early diagnosis has boosted the demand for accurate and minimally invasive biopsy techniques. Technological advancements, including real-time 3D imaging and robotic-assisted biopsy devices, enhance diagnostic accuracy and procedural efficiency, further driving market growth. Additionally, government initiatives supporting breast cancer awareness and screening programs in both developed and emerging economies contribute to broader market adoption.

Market Restraints:

Despite its strong growth trajectory, the breast biopsy market faces challenges such as high procedural costs and limited accessibility in low-income regions. Invasive nature of some biopsy procedures and patient anxiety regarding the process can hinder adoption, particularly in settings with limited healthcare infrastructure. Moreover, stringent regulatory approvals for new biopsy systems and concerns regarding false-negative results in certain techniques may impact market confidence and slow adoption of advanced technologies. Addressing these issues requires industry-wide focus on innovation, affordability, and patient education.

Market Opportunities:

The breast biopsy market presents lucrative opportunities through technological integration, such as AI-based diagnostic support tools, smart imaging systems, and portable biopsy devices for use in remote and resource-constrained settings. Expanding private and public healthcare investments in cancer care infrastructure, especially in Asia Pacific and Latin America, opens new growth avenues. Furthermore, the trend toward outpatient and home-based diagnostic procedures is expected to stimulate demand for compact and user-friendly biopsy systems. Strategic collaborations with healthcare providers, research institutions, and digital health platforms can enhance product offerings and increase market penetration.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the breast biopsy market globally?
• Which biopsy types and imaging modalities are preferred across various clinical settings?
• How are innovations in imaging and device miniaturization reshaping the market landscape?
• Who are the key players in the breast biopsy market, and what strategic initiatives are they pursuing?
• What emerging trends and opportunities are expected to define the future of breast biopsy technologies?

Competitive Intelligence and Business Strategy:

These companies invest heavily in R&D to develop next-generation biopsy tools with enhanced precision, speed, and patient comfort. Collaborative efforts with imaging solution providers and research hospitals aim to integrate AI and machine learning for improved diagnostic outcomes. Market leaders also focus on regulatory approvals, clinical validation, and physician training programs to drive adoption and maintain competitive advantage.

Key Companies Profiled:

• Argon Medical Devices
• Becton Dickinson and Company
• C. R. Bard, Inc.
• Cook Medical Inc.
• Devicor Medical Products, Inc.
• F. Hoffmann-La Roche Ltd.
• GE Healthcare
• Hologic, Inc.
• Leica Biosystems
• Medax Srl Unipersonale
• Planmed Oy
• Scion Medical Technologies, LLC
• Siemens Healthineer

Breast Biopsy Market Research Segmentation:

Product:

• Biopsy Needles
  • * Core Needles
  • * Fine Aspiration Needles
• MRI-Guide Biopsy Systems
• Ultrasound Guided Breast Biopsy Systems
  • * Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
  • * Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
• Vacuum-Assisted Devices (VAD)
• Guide Wire (Localization Wire)
• Breast Biopsy Markers

Indication:

• Complex Cysts
• Solid Mass
• Suspicious Solid Mass (Fibroadenoma)
• Suspicious Micro-calcifications

End User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Cancer Research Institutes

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Global Breast Biopsy Market Snapshot 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Industry Developments and Key Market Events
• 1.5. Demand Side and Supply Side Analysis
• 1.6. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definitions
• 2.2. Value Chain Analysis
• 2.3. Macro-Economic Factors
  • 2.3.1. Global GDP Outlook
  • 2.3.2. Global GDP Outlook
  • 2.3.3. Global economic Growth Forecast
  • 2.3.4. Global Urbanization Growth
  • 2.3.5. Other Macro-economic Factors
• 2.4. Forecast Factors - Relevance and Impact
• 2.5. COVID-19 Impact Assessment
• 2.6. PESTLE Analysis
• 2.7. Porter's Five Forces Analysis
• 2.8. Geopolitical Tensions: Market Impact
• 2.9. Regulatory and Technology Landscape

3. Market Dynamics

• 3.1. Drivers
• 3.2. Restraints
• 3.3. Opportunities
• 3.4. Trends

4. Price Trend Analysis, 2019-2032

• 4.1. Region-wise Price Analysis
• 4.2. Price by Segments
• 4.3. Price Impact Factors

5. Global Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 5.1. Key Highlights
• 5.2. Global Breast Biopsy Market Outlook: Product
  • 5.2.1. Introduction/Key Findings
  • 5.2.2. Historical Market Size (US$ Mn) Analysis by Product, 2019-2024
  • 5.2.3. Current Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 5.2.3.1. Biopsy Needles
      • 5.2.3.1.1. Core Needles
      • 5.2.3.1.2. Fine Aspiration Needles
    • 5.2.3.2. MRI-Guide Biopsy Systems
    • 5.2.3.3. Ultrasound Guided Breast Biopsy Systems
      • 5.2.3.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
      • 5.2.3.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 5.2.3.4. Vacuum-Assisted Devices (VAD)
    • 5.2.3.5. Guide Wire (Localization Wire)
    • 5.2.3.6. Breast Biopsy Markers
  • 5.2.4. Market Attractiveness Analysis: Product
• 5.3. Global Breast Biopsy Market Outlook: Indication
  • 5.3.1. Introduction/Key Findings
  • 5.3.2. Historical Market Size (US$ Mn) Analysis by Indication, 2019-2024
  • 5.3.3. Current Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 5.3.3.1. Complex Cysts
    • 5.3.3.2. Solid Mass
    • 5.3.3.3. Suspicious Solid Mass (Fibroadenoma)
    • 5.3.3.4. Suspicious Micro-calcifications
  • 5.3.4. Market Attractiveness Analysis: Indication
• 5.4. Global Breast Biopsy Market Outlook: End User
  • 5.4.1. Introduction/Key Findings
  • 5.4.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2024
  • 5.4.3. Current Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 5.4.3.1. Hospitals
    • 5.4.3.2. Specialty Clinics
    • 5.4.3.3. Ambulatory Surgical Centers
    • 5.4.3.4. Cancer Research Institutes
  • 5.4.4. Market Attractiveness Analysis: End User

6. Global Breast Biopsy Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
• 6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia & Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. North America Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 7.4.1. Biopsy Needles
    • 7.4.1.1. Core Needles
    • 7.4.1.2. Fine Aspiration Needles
  • 7.4.2. MRI-Guide Biopsy Systems
  • 7.4.3. Ultrasound Guided Breast Biopsy Systems
    • 7.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
    • 7.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
  • 7.4.4. Vacuum-Assisted Devices (VAD)
  • 7.4.5. Guide Wire (Localization Wire)
  • 7.4.6. Breast Biopsy Markers
• 7.5. North America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 7.5.1. Complex Cysts
  • 7.5.2. Solid Mass
  • 7.5.3. Suspicious Solid Mass (Fibroadenoma)
  • 7.5.4. Suspicious Micro-calcifications
• 7.6. North America Market Size (US$ Mn) Forecast, by End User, 2025-2032
  • 7.6.1. Hospitals
  • 7.6.2. Specialty Clinics
  • 7.6.3. Ambulatory Surgical Centers
  • 7.6.4. Cancer Research Institutes

8. Europe Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 8.3.1. Germany
  • 8.3.2. Italy
  • 8.3.3. France
  • 8.3.4. U.K.
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Rest of Europe
• 8.4. Europe Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 8.4.1. Biopsy Needles
    • 8.4.1.1. Core Needles
    • 8.4.1.2. Fine Aspiration Needles
  • 8.4.2. MRI-Guide Biopsy Systems
  • 8.4.3. Ultrasound Guided Breast Biopsy Systems
    • 8.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
    • 8.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
  • 8.4.4. Vacuum-Assisted Devices (VAD)
  • 8.4.5. Guide Wire (Localization Wire)
  • 8.4.6. Breast Biopsy Markers
• 8.5. Europe Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 8.5.1. Complex Cysts
  • 8.5.2. Solid Mass
  • 8.5.3. Suspicious Solid Mass (Fibroadenoma)
  • 8.5.4. Suspicious Micro-calcifications
• 8.6. Europe Market Size (US$ Mn) Forecast, by End User, 2025-2032
  • 8.6.1. Hospitals
  • 8.6.2. Specialty Clinics
  • 8.6.3. Ambulatory Surgical Centers
  • 8.6.4. Cancer Research Institutes

9. East Asia Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. East Asia Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 9.4.1. Biopsy Needles
    • 9.4.1.1. Core Needles
    • 9.4.1.2. Fine Aspiration Needles
  • 9.4.2. MRI-Guide Biopsy Systems
  • 9.4.3. Ultrasound Guided Breast Biopsy Systems
    • 9.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
    • 9.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
  • 9.4.4. Vacuum-Assisted Devices (VAD)
  • 9.4.5. Guide Wire (Localization Wire)
  • 9.4.6. Breast Biopsy Markers
• 9.5. East Asia Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 9.5.1. Complex Cysts
  • 9.5.2. Solid Mass
  • 9.5.3. Suspicious Solid Mass (Fibroadenoma)
  • 9.5.4. Suspicious Micro-calcifications
• 9.6. East Asia Market Size (US$ Mn) Forecast, by End User, 2025-2032
  • 9.6.1. Hospitals
  • 9.6.2. Specialty Clinics
  • 9.6.3. Ambulatory Surgical Centers
  • 9.6.4. Cancer Research Institutes

10. South Asia & Oceania Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of SAO
• 10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 10.4.1. Biopsy Needles
    • 10.4.1.1. Core Needles
    • 10.4.1.2. Fine Aspiration Needles
  • 10.4.2. MRI-Guide Biopsy Systems
  • 10.4.3. Ultrasound Guided Breast Biopsy Systems
    • 10.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
    • 10.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
  • 10.4.4. Vacuum-Assisted Devices (VAD)
  • 10.4.5. Guide Wire (Localization Wire)
  • 10.4.6. Breast Biopsy Markers
• 10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 10.5.1. Complex Cysts
  • 10.5.2. Solid Mass
  • 10.5.3. Suspicious Solid Mass (Fibroadenoma)
  • 10.5.4. Suspicious Micro-calcifications
• 10.6. South Asia & Oceania Market Size (US$ Mn) Forecast, by End User, 2025-2032
  • 10.6.1. Hospitals
  • 10.6.2. Specialty Clinics
  • 10.6.3. Ambulatory Surgical Centers
  • 10.6.4. Cancer Research Institutes

11. Latin America Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 11.1. Key Highlights
• 11.2. Pricing Analysis
• 11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of LATAM
• 11.4. Latin America Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 11.4.1. Biopsy Needles
    • 11.4.1.1. Core Needles
    • 11.4.1.2. Fine Aspiration Needles
  • 11.4.2. MRI-Guide Biopsy Systems
  • 11.4.3. Ultrasound Guided Breast Biopsy Systems
    • 11.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
    • 11.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
  • 11.4.4. Vacuum-Assisted Devices (VAD)
  • 11.4.5. Guide Wire (Localization Wire)
  • 11.4.6. Breast Biopsy Markers
• 11.5. Latin America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 11.5.1. Complex Cysts
  • 11.5.2. Solid Mass
  • 11.5.3. Suspicious Solid Mass (Fibroadenoma)
  • 11.5.4. Suspicious Micro-calcifications
• 11.6. Latin America Market Size (US$ Mn) Forecast, by End User, 2025-2032
  • 11.6.1. Hospitals
  • 11.6.2. Specialty Clinics
  • 11.6.3. Ambulatory Surgical Centers
  • 11.6.4. Cancer Research Institutes

12. Middle East & Africa Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 12.1. Key Highlights
• 12.2. Pricing Analysis
• 12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 12.3.1. GCC Countries
  • 12.3.2. South Africa
  • 12.3.3. Northern Africa
  • 12.3.4. Rest of MEA
• 12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 12.4.1. Biopsy Needles
    • 12.4.1.1. Core Needles
    • 12.4.1.2. Fine Aspiration Needles
  • 12.4.2. MRI-Guide Biopsy Systems
  • 12.4.3. Ultrasound Guided Breast Biopsy Systems
    • 12.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
    • 12.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
  • 12.4.4. Vacuum-Assisted Devices (VAD)
  • 12.4.5. Guide Wire (Localization Wire)
  • 12.4.6. Breast Biopsy Markers
• 12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 12.5.1. Complex Cysts
  • 12.5.2. Solid Mass
  • 12.5.3. Suspicious Solid Mass (Fibroadenoma)
  • 12.5.4. Suspicious Micro-calcifications
• 12.6. Middle East & Africa Market Size (US$ Mn) Forecast, by End User, 2025-2032
  • 12.6.1. Hospitals
  • 12.6.2. Specialty Clinics
  • 12.6.3. Ambulatory Surgical Centers
  • 12.6.4. Cancer Research Institutes

13. Competition Landscape

• 13.1. Market Share Analysis, 2025
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles
  • 13.3.1. Argon Medical
    • 13.3.1.1. Company Overview
    • 13.3.1.2. Product Portfolio/Offerings
    • 13.3.1.3. Key Financials
    • 13.3.1.4. SWOT Analysis
    • 13.3.1.5. Company Strategy and Key Developments
  • 13.3.2. Becton Dickinson and Company
  • 13.3.3. C.R. Bard, Inc.
  • 13.3.4. Cook Medical Inc.
  • 13.3.5. Devicor Medical Products, Inc.
  • 13.3.6. F. Hoffmann-La Roche Ltd.,
  • 13.3.7. GE Healthcare
  • 13.3.8. Hologic, Inc.
  • 13.3.9. Leica Biosystems
  • 13.3.10. Medax Srl Unipersonale
  • 13.3.11. Planmed Oy
  • 13.3.12. Scion Medical Technologies, LLC
  • 13.3.13. Siemens Healthineers
  • 13.3.14. Hikma Pharmaceuticals
  • 13.3.15. Incytes

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations